Maternal Blood Sugar Levels Linked to Heightened Obesity Risk in Adolescents
The study challenges traditional clinical thresholds that focus primarily on full-blown gestational diabetes mellitus (GDM). Instead, it highlights a spectrum…
Disease Prevention & Management
Amara Maple NYU Langone Health Appoints Marcus D. Goncalves MD PhD as Director of the Holman Division of Endocrinology Diabetes and Metabolism
NYU Langone Health has officially announced the appointment of Marcus D. Goncalves, MD, PhD, as the new director of the…
Inflammation-associated Lipidomic Signatures Prior to Carotid Artery Atherosclerosis in People Living With HIV.
This landmark study, recently published in The Journal of Clinical Endocrinology & Metabolism, reveals a breakthrough in cardiovascular risk assessment…
FDA Approval and Launch of 25 mg Oral Semaglutide Marks a New Era in Chronic Weight Management and Cardiovascular Risk Reduction
The landscape of metabolic medicine underwent a significant transformation in early January 2026 as the 25 mg oral formulation of…
Endocrine Society Advocacy Win: Congress Increases FY 2026 NIH Funding
The United States Congress has finalized and passed a comprehensive funding bill for the Department of Health and Human Services…
The Endocrine Society Launches Rare Endocrine Disease Fellows Program to Address Critical Gaps in Specialized Medical Training and Patient Care
The Endocrine Society has officially announced the commencement of its Rare Endocrine Disease (RED) Fellows Program, a comprehensive educational initiative…
Eli Lilly Announces Pivotal Phase 3 Success for Orforglipron as Oral GLP-1 Agonist Demonstrates Superiority in Global Diabetes Trials
In a landmark development for the treatment of type 2 diabetes and metabolic health, Eli Lilly and Company has announced…
New Research Challenges Fears of Semaglutide-Linked Thyroid Cancer Risk
The study provides a detailed roadmap of how semaglutide interacts with the tumor microenvironment (TME), specifically targeting immune cells known…
Advances in Incretin-Based Therapies: Transformative Research and Real-World Challenges in Obesity and Cardiovascular Care
In observance of American Heart Month this February, the medical community is intensifying its focus on the intersection of metabolic…
The Cardiovascular Impact of GLP-1 Receptor Agonists New Research Insights into Tirzepatide and Comparative Efficacy in Type 2 Diabetes Management
As the pharmaceutical landscape undergoes a seismic shift driven by the proliferation of anti-obesity and glucose-lowering medications, the medical community…
